Back
Alnylam Pharmaceuticals Vs. Strategy Industry Stock Comparison
Sell
15
ALNY
Alnylam Pharmaceuticals
Last Price:
$235.61
Seasonality Move:
8.79%
Sell
42
MSTR
Strategy
Last Price:
$293.21
Seasonality Move:
-2.3%
Sell
15
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $235.74. The Score for ALNY is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
42
Strategy (MSTR)
is a Sell
Is Strategy a Buy, Sell or Hold?
-
MSTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $235.74Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.99 | Buy |
| Relative Strength Index (14 RSI): | 39.34 | Sell |
| Chaikin Money Flow: | -1854512 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (241 - 270.88) | Sell |
| Bollinger Bands (100): | (240.22 - 269.34) | Sell |
MSTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.04 | Sell |
| Relative Strength Index (14 RSI): | 48.14 | Sell |
| Chaikin Money Flow: | 16725760 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (270.26 - 318.26) | Sell |
| Bollinger Bands (100): | (289.8 - 381.04) | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 262.4 | Sell |
| 20-day SMA: | 258.39 | Sell |
| 50-day SMA: | 260.65 | Sell |
| 200-day SMA: | 256.54 | Sell |
| 8-day EMA: | 258.73 | Sell |
| 20-day EMA: | 259.55 | Sell |
| 50-day EMA: | 257.83 | Sell |
| 200-day EMA: | 245.23 | Sell |
MSTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 303.25 | Sell |
| 20-day SMA: | 298.12 | Sell |
| 50-day SMA: | 310.39 | Sell |
| 200-day SMA: | 247.98 | Buy |
| 8-day EMA: | 300.09 | Sell |
| 20-day EMA: | 301.21 | Sell |
| 50-day EMA: | 307.49 | Sell |
| 200-day EMA: | 259.51 | Buy |
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $1.34 per share, an increase this year of $1.21 per share, and an increase next year of $2.83 per share.
Strategy Earnings Growth & MSTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $38.16 per share, an increase this year of $2.96 per share, and an increase next year of $0.01 per share.
Alnylam Pharmaceuticals Technical Analysis
| Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Strategy Technical Analysis
| Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||